A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH).

导出 LinkOut

翻译打印收藏纠错

第一作者： Adam N,Berman

第一单位： Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Massachusetts General Physicians Organization, Boston, MA.

作者： Adam N,Berman ^[1] ; Curtis,Ginder ^[2] ; Xianghong S,Wang ^[3] ; Linnea,Borden ^[4] ; Michael K,Hidrue ^[3] ; Jennifer M,Searl Como ^[4] ; Danielle,Daly ^[4] ; Yee-Ping,Sun ^[2] ; William T,Curry ^[5] ; Marcela,Del Carmen ^[5] ; David A,Morrow ^[2] ; Benjamin,Scirica ^[2] ; Niteesh K,Choudhry ^[6] ; James L,Januzzi ^[7] ; Jason H,Wasfy ^[8]

作者单位： Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Massachusetts General Physicians Organization, Boston, MA. ^[1] Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. ^[2] Division of Performance Analysis and Improvement, Massachusetts General Physicians Organization, Boston, MA. ^[3] Massachusetts General Physicians Organization, Boston, MA. ^[4] Massachusetts General Physicians Organization, Boston, MA; Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA. ^[5] Department of Medicine, Center for Healthcare Delivery Sciences, Brigham and Women's Hospital, Harvard Medical School, Boston, MA. ^[6] Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Heart Failure and Biomarker Trials, Baim Institute for Clinical Research, Boston, MA. ^[7] Massachusetts General Physicians Organization, Boston, MA; Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Electronic address: jwasfy@mgh.harvard.edu. ^[8]

关键词 Cardiomyopathies Cardiovascular population health LVH Left ventricular hypertrophy Pragmatic clinical trial Undiagnosed hypertension

DOI 10.1016/j.ahj.2023.06.014

PMID 37454754

发布时间 2023-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

American heart journal

2023年265卷

40-49页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH).

American heart journal

相似文献

American heart journal

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A pragmatic clinical trial assessing the effect of a targeted notification and clinical support pathway on the diagnostic evaluation and treatment of individuals with left ventricular hypertrophy (NOTIFY-LVH).

American heart journal

相似文献

American heart journal

相关期刊

检索历史清除